What does CUSIP 77313F106 represent in this 13F holders report?

CUSIP 77313F106 is the security identifier for RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in Q1 2024?

183 institutional investors reported RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock for Q1 2024. Use the holders table for investor-level position and value details.

ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)

CUSIP: 77313F106

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / Common Stock
Shares outstanding: 109,265,652
Total 13F shares: 92,048,164
Share change: +4,173,178
Total reported value: $2,479,705,726
Put/Call ratio: 46%
Price per share: $26.94
Number of holders: 183
Value change: +$111,013,838
Number of buys: 86
Number of sells: 87

Quarterly Holders Quick Answers

What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 77313F106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	— mixed-class rows	18,037,772 mixed-class rows	$530,274,027	—	31 Dec 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	7.5%	8,197,546	$245,680,453	—	31 Dec 2023	13F
BlackRock Finance, Inc.	13F	Company	5.4%	5,930,178	$177,727,435	—	31 Dec 2023	13F
VANGUARD GROUP INC	13F	Company	5%	5,447,565	$163,263,523	—	31 Dec 2023	13F
MAVERICK CAPITAL LTD	13F	Company	3.7%	4,034,068	$120,901,018	—	31 Dec 2023	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	3.6%	3,941,859	$118,137,514	—	31 Dec 2023	13F
STATE STREET CORP	13F	Company	3%	3,231,411	$96,845,388	—	31 Dec 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.4%	2,629,074	$78,794,000	—	31 Dec 2023	13F
CITADEL ADVISORS LLC	13F	Company	— mixed-class rows	2,757,861 mixed-class rows	$73,800,251	—	31 Dec 2023	13F
Avidity Partners Management LP	13F	Company	1.6%	1,719,103	$51,521,517	—	31 Dec 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.6%	1,707,398	$51,170,718	—	31 Dec 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	1.4%	1,523,013	$45,644,700	—	31 Dec 2023	13F
Boxer Capital, LLC	13F	Company	1.3%	1,466,051	$43,937,548	—	31 Dec 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	1,457,250	$43,679,432	—	31 Dec 2023	13F
Pictet Asset Management Holding SA	13F	Company	1.2%	1,347,163	$40,374,475	—	31 Dec 2023	13F
Logos Global Management LP	13F	Company	1.2%	1,275,000	$38,211,750	—	31 Dec 2023	13F
Avoro Capital Advisors LLC	13F	Company	1.2%	1,260,900	$37,789,173	—	31 Dec 2023	13F
COWEN AND COMPANY, LLC	13F	Company	— mixed-class rows	1,131,663 mixed-class rows	$32,982,514	—	31 Dec 2023	13F
FRANKLIN RESOURCES INC	13F	Company	0.98%	1,072,910	$32,155,113	—	31 Dec 2023	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.98%	1,069,715	$32,059,359	—	31 Dec 2023	13F
BAMCO INC /NY/	13F	Company	0.96%	1,052,501	$31,543,455	—	31 Dec 2023	13F
Novo Holdings A/S	13F	Company	0.96%	1,050,000	$31,468,500	—	31 Dec 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.96%	1,047,941	$31,408,737	—	31 Dec 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.87%	949,905	$28,425,926	—	31 Dec 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.73%	793,738	$23,788,327	—	31 Dec 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.68%	748,340	$22,427,750	—	31 Dec 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.64%	702,625	$21,057,671	—	31 Dec 2023	13F
Russell Investments Group, Ltd.	13F	Company	0.59%	648,946	$19,448,927	—	31 Dec 2023	13F
NORTHERN TRUST CORP	13F	Company	0.58%	628,705	$18,842,289	—	31 Dec 2023	13F
MORGAN STANLEY	13F	Company	0.56%	611,973	$18,340,831	—	31 Dec 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.54%	594,665	$17,822,097	—	31 Dec 2023	13F
COMERICA BANK	13F	Company	0.51%	558,025	$16,724,009	—	31 Dec 2023	13F
FMR LLC	13F	Company	0.48%	529,496	$15,868,992	—	31 Dec 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.48%	525,452	$15,747,796	—	31 Dec 2023	13F
M28 Capital Management LP	13F	Company	0.48%	523,280	$15,682,702	—	31 Dec 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.45%	490,732	$14,707,238	—	31 Dec 2023	13F
Cormorant Asset Management, LP	13F	Company	0.41%	450,000	$13,486,500	—	31 Dec 2023	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	— mixed-class rows	487,500 mixed-class rows	$11,520,046	—	31 Dec 2023	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.33%	366,015	$10,969,470	—	31 Dec 2023	13F
GMT CAPITAL CORP	13F	Company	0.28%	306,500	$9,185,805	—	31 Dec 2023	13F
WCM INVESTMENT MANAGEMENT, LLC	13F	Company	0.27%	296,013	$9,146,802	—	31 Dec 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.23%	254,916	$7,639,833	—	31 Dec 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.23%	250,000	$7,492,500	—	31 Dec 2023	13F
NORGES BANK	13F	Company	0.22%	243,351	$7,293,229	—	31 Dec 2023	13F
Ikarian Capital, LLC	13F	Company	0.22%	239,726	$7,184,588	—	31 Dec 2023	13F
Bank of New York Mellon Corp	13F	Company	0.21%	232,490	$6,967,724	—	31 Dec 2023	13F
Privium Fund Management B.V.	13F	Company	0.21%	233,050	$6,874,975	—	31 Dec 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.19%	208,505	$6,248,895	—	31 Dec 2023	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.18%	193,350	$5,794,700	—	31 Dec 2023	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.17%	190,783	$5,717,767	—	31 Dec 2023	13F

Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q1 2024

As of 31 Mar 2024, ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by 183 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,048,164 shares. The largest 10 holders included RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WESTFIELD CAPITAL MANAGEMENT CO LP, MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC. This page lists 183 institutional shareholders reporting positions in this security for the Q1 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders

192

Q1 2024 holders

183

Holder diff

-9

Investor	Q4 2023 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q4 2023 Value $	Q1 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.